The Association of Aging Biomarkers, Interstitial Lung Abnormalities, and Mortality
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Rationale: The association between aging and idiopathic pulmonary fibrosis has been established. The associations between aging-related biomarkers and interstitial lung abnormalities (ILA) have not been comprehensively evaluated. Objectives: To evaluate the associations among aging biomarkers, ILA, and all-cause mortality. Methods: In the FHS (Framingham Heart Study), we evaluated associations among plasma biomarkers (IL-6, CRP [C-reactive protein], TNFR [tumor necrosis factor α receptor II], GDF15 [growth differentiation factor 15], cystatin-C, HGBA1C [Hb A1C], insulin, IGF1 [insulin-like growth factor 1], and IGFBP1 [IGF binding protein 1] and IGFBP3]), ILA, and mortality. Causal inference analysis was used to determine whether biomarkers mediated age. GDF15 results were replicated in the COPDGene (Genetic Epidemiology of Chronic Obstructive Pulmonary Disease) Study. Measurements and Main Results: In the FHS, there were higher odds of ILA per increase in natural log–transformed GDF15 (odds ratio [95% confidence interval], 3.4 [1.8–6.4]; P = 0.0002), TNFR (3.1 [1.6–5.8]; P = 0.004), IL-6 (1.8 [1.4–2.4]; P < 0.0001), and CRP (1.7 [1.3–2.0]; P < 0.0001). In the FHS, after adjustment for multiple comparisons, no biomarker was associated with increased mortality, but the associations of GDF15 (hazard ratio, 2.0 [1.1–3.5]; P = 0.02), TNFR (1.8 [1.0–3.3]; P = 0.05), and IGFBP1 (1.3 [1.1–1.7]; P = 0.01) approached significance. In the COPDGene Study, higher natural log–transformed GDF15 was associated with ILA (odds ratio, 8.1 [3.1–21.4]; P < 0.0001) and mortality (hazard ratio, 1.6 [1.1–2.2]; P = 0.01). Causal inference analysis showed that the association of age with ILA was mediated by IL-6 (P < 0.0001) and TNFR (P = 0.002) and was likely mediated by GDF15 (P = 0.008) in the FHS and was mediated by GDF15 (P = 0.001) in the COPDGene Study. Conclusions: Some aging-related biomarkers are associated with ILA. GDF15, in particular, may explain some of the associations among age, ILA, and mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is an association between the upregulation of GDF15, IL-6, CRP and TNFRSF1B in plasma with the susceptibility of the occurrence of interstitial lung abnormalities179.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [179]
Citations
Cites
Quantification of coronary artery calcium using ultrafast computed tomography
Agatston, A. S., Janowitz, W. R., Hildner, F. J., Zusmer, N. R., Viamonte, M., & Detrano, R. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90282-t · Cited by 7,786
Geroscience: Linking Aging to Chronic Disease
Kennedy, B. K., Berger, S. L., Brunet, A., Campisi, J., Cuervo, A. M., Epel, E. S., Franceschi, C., Lithgow, G. J., Morimoto, R. I., Pessin, J. E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.10.039 · Cited by 2,764
Epidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
A proteomic atlas of senescence-associated secretomes for aging biomarker development
Basisty, N., Kale, A., Jeon, O. H., Kuehnemann, C., Payne, T., Rao, C., Holtz, A., Shah, S., Sharma, V., Ferrucci, L., et al. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000599 · Cited by 1,348
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
Justice, J. N., Nambiar, A. M., Tchkonia, T., LeBrasseur, N. K., Pascual, R., Hashmi, S. K., Prata, L., Masternak, M. M., Kritchevsky, S. B., Musi, N., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.052 · Cited by 1,261
MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily
Bootcov, M. R., Bauskin, A. R., Valenzuela, S. M., Moore, A. G., Bansal, M., He, X. Y., Zhang, H. P., Donnellan, M., Mahler, S., Pryor, K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11514 · Cited by 1,177
Pathogenesis of Idiopathic Pulmonary Fibrosis
Wolters, P. J., Collard, H. R., & Jones, K. D. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104706 · Cited by 862
Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities
Washko, G. R., Hunninghake, G. M., Fernandez, I. E., Nishino, M., Okajima, Y., Yamashiro, T., Ross, J. C., Estépar, R. S. J., Lynch, D. A., Brehm, J. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007285 · Cited by 611
Self-citationHatabu, H., Hunninghake, G. M., Richeldi, L., Brown, K. K., Wells, A. U., Remy-Jardin, M., Verschakelen, J., Nicholson, A. G., Beasley, M. B., Christiani, D. C., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30168-5 · Cited by 591
Self-citationMMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis
Rosas, I. O., Richards, T. J., Konishi, K., Zhang, Y., Gibson, K., Lokshin, A. E., Lindell, K. O., Cisneros, J., MacDonald, S. D., Pardo, A., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050093 · Cited by 588
GDF15 mediates the effects of metformin on body weight and energy balance
Coll, A. P., Chen, M., Taskar, P., Rimmington, D., Patel, S., Tadross, J. A., Cimino, I., Yang, M., Welsh, P., Virtue, S., et al. (2020) · Nature · doi:10.1038/s41586-019-1911-y · Cited by 584
Plasma proteomic signature of age in healthy humans
Tanaka, T., Biancotto, A., Moaddel, R., Moore, A. Z., Gonzalez‐Freire, M., Aon, M. A., Candia, J., Zhang, P., Cheung, F., Fantoni, G., et al. (2018) · Aging Cell · doi:10.1111/acel.12799 · Cited by 562
Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease
Wollert, K. C., Kempf, T., & Wallentin, L. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.255174 · Cited by 559
Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3
MacKinnon, A. C., Gibbons, M. A., Farnworth, S. L., Leffler, H., Nilsson, U. J., Delaine, T., Simpson, A. J., Forbes, S. J., Hirani, N., Gauldie, J., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201106-0965oc · Cited by 516
Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study
Wang, T. J., Wollert, K. C., Larson, M. G., Coglianese, E., McCabe, E. L., Cheng, S., Ho, J. E., Fradley, M. G., Ghorbani, A., Xanthakis, V., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.129437 · Cited by 482
Self-citationAssociation Between Interstitial Lung Abnormalities and All-Cause Mortality
Putman, R. K., Hatabu, H., Araki, T., Gudmundsson, G., Gao, W., Nishino, M., Okajima, Y., Dupuis, J., Latourelle, J. C., Cho, M. H., et al. (2016) · JAMA · doi:10.1001/jama.2016.0518 · Cited by 473
Self-citationMUC5B Promoter Polymorphism and Interstitial Lung Abnormalities
Hunninghake, G. M., Hatabu, H., Okajima, Y., Gao, W., Dupuis, J., Latourelle, J. C., Nishino, M., Araki, T., Zazueta, O. E., Kurugol, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1216076 · Cited by 456
Self-citationDanazol Treatment for Telomere Diseases
Townsley, D. M., Dumitriu, B., Liu, D., Biancotto, A., Weinstein, B., Chen, C., Hardy, N., Mihalek, A. D., Lingala, S., Kim, Y. J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515319 · Cited by 415
Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis
Richards, T. J., Kaminski, N., Baribaud, F., Flavin, S., Brodmerkel, C., Horowitz, D., Li, K., Choi, J., Vuga, L. J., Lindell, K. O., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0058oc · Cited by 381
Justice, J. N., Ferrucci, L., Newman, A. B., Aroda, V. R., Bahnson, J. L., Divers, J., Espeland, M. A., Marcovina, S., Pollak, M. N., Kritchevsky, S. B., et al. (2018) · GeroScience · doi:10.1007/s11357-018-0042-y · Cited by 359
Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study
Araki, T., Putman, R. K., Hatabu, H., Gao, W., Dupuis, J., Latourelle, J. C., Nishino, M., Zazueta, O. E., Kurugol, S., Ross, J. C., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2523oc · Cited by 348
Self-citationStuart, B. D., Lee, J. S., Kozlitina, J., Noth, I., Devine, M. S., Glazer, C. S., Torres, F., Kaza, V., Girod, C. E., Jones, K. D., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70124-9 · Cited by 310
Protein Biomarkers of Cardiovascular Disease and Mortality in the Community
Ho, J. E., Lyass, A., Courchesne, P., Chen, G., Liu, C., Yin, X., Hwang, S., Massaro, J. M., Larson, M. G., & Levy, D. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.008108 · Cited by 269
Self-citationImaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality
Putman, R. K., Gudmundsson, G., Axelsson, G. T., Hida, T., Honda, O., Araki, T., Yanagawa, M., Nishino, M., Miller, E. R., Eiriksdottir, G., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201809-1652oc · Cited by 261
Self-citationDaniels, L. B., Clopton, P., Laughlin, G. A., Maisel, A. S., & Barrett-Connor, E. (2011) · Circulation · doi:10.1161/circulationaha.110.979740 · Cited by 247
The in vivo gene expression signature of oxidative stress
Han, E.-S., Muller, F. L., Pérez, V. I., Qi, W., Liang, H., Xi, L., Fu, C., Doyle, E., Hickey, M., Cornell, J., et al. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00239.2007 · Cited by 233
Fujita, Y., Taniguchi, Y., Shinkai, S., Tanaka, M., & Ito, M. (2016) · Geriatrics & Gerontology International · doi:10.1111/ggi.12724 · Cited by 198
Kropski, J. A., Pritchett, J. M., Zoz, D. F., Crossno, P. F., Markin, C., Garnett, E. T., Degryse, A. L., Mitchell, D. B., Polosukhin, V. V., Rickman, O. B., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201406-1162oc · Cited by 178
Rohatgi, A., Patel, P., Das, S. R., Ayers, C. R., Khera, A., Martinez-Rumayor, A., Berry, J. D., McGuire, D. K., & de Lemos, J. A. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.171926 · Cited by 178
High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study
Podolanczuk, A. J., Oelsner, E. C., Barr, R. G., Hoffman, E. A., Armstrong, H. F., Austin, J. H. M., Basner, R. C., Bartels, M. N., Christie, J. D., Enright, P. L., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00129-2016 · Cited by 167
Emmerson, P. J., Duffin, K. L., Chintharlapalli, S., & Wu, X. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01712 · Cited by 167
Interstitial Lung Abnormalities and Reduced Exercise Capacity
Doyle, T. J., Washko, G. R., Fernandez, I. E., Nishino, M., Okajima, Y., Yamashiro, T., Divo, M. J., Celli, B. R., Sciurba, F. C., Silverman, E. K., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201109-1618oc · Cited by 144
Self-citationOverlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis
Hobbs, B. D., Putman, R. K., Araki, T., Nishino, M., Guðmundsson, G., Gudnason, V. G., Eiríksdóttir, G., Zilhäo, N. R., Dupuis, J., Xu, H., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0511oc · Cited by 126
Self-citationHistopathology of Interstitial Lung Abnormalities in the Context of Lung Nodule Resections
Miller, E. R., Putman, R. K., Vivero, M., Hung, Y. P., Araki, T., Nishino, M., Washko, G. R., Rosas, I. O., Hatabu, H., Sholl, L. M., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201708-1679le · Cited by 120
Self-citationThe Aging Lung and Idiopathic Pulmonary Fibrosis
Gulati, S., & Thannickal, V. J. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.02.008 · Cited by 111
Brown, D. A., Stephan, C., Ward, R. L., Law, M., Hunter, M., Bauskin, A. R., Amin, J., Jung, K., Diamandis, E. P., Hampton, G. M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1331 · Cited by 109
Nickel, N. P., Jonigk, D. D., Kempf, T., Bockmeyer, C. L., Maegel, L., Rische, J., Laenger, F., Lehmann, U., Sauer, C., Greer, M., et al. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-62 · Cited by 108
GDF15 is an epithelial-derived biomarker of idiopathic pulmonary fibrosis
Zhang, Y., Jiang, M., Nouraie, M., Roth, M. G., Tabib, T., Winters, S., Chen, X., Sembrat, J., Chu, Y., Cardenes, N., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00062.2019 · Cited by 107
Justice, J., Miller, J. D., Newman, J. C., Hashmi, S. K., Halter, J., Austad, S. N., Barzilai, N., & Kirkland, J. L. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw126 · Cited by 96
TheMUC5Bpromoter polymorphism is associated with specific interstitial lung abnormality subtypes
Putman, R. K., Guðmundsson, G., Araki, T., Nishino, M., Sigurdsson, S. O., Gudmundsson, E. F., Eiríksdóttir, G., Aspelund, T., Ross, J. C., Estépar, R. S. J., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00537-2017 · Cited by 82
Self-citationGalectin-3 Is Associated with Restrictive Lung Disease and Interstitial Lung Abnormalities
Ho, J. E., Gao, W. D., Levy, D. A., Santhanakrishnan, R., Araki, T., Rosas, I. O., Hatabu, H., Latourelle, J. C., Nishino, M., Dupuis, J., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201509-1753oc · Cited by 80
Self-citationInterstitial lung abnormalities: erecting fences in the path towards advanced pulmonary fibrosis
Hunninghake, G. M. (2019) · Thorax · doi:10.1136/thoraxjnl-2018-212446 · Cited by 67
Self-citationGDF-15 in Pulmonary and Critical Care Medicine
Verhamme, F. M., Freeman, C. M., Brusselle, G., Bracke, K. R., & Curtis, J. L. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0379tr · Cited by 50
Self-citationArmstrong, H. F., Podolanczuk, A. J., Barr, R. G., Oelsner, E. C., Kawut, S. M., Hoffman, E. A., Tracy, R., Kaminski, N., McClelland, R. L., & Lederer, D. J. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0254oc · Cited by 47
Pompe, E., de Jong, P. A., Lynch, D. A., Leßmann, N., Išgum, I., van Ginneken, B., Lammers, J. J., & Hoesein, F. A. A. M. (2017) · European Respiratory Journal · doi:10.1183/13993003.01814-2016 · Cited by 40
for the COPDGene Investigators, Martinez, C. H., Freeman, C. M., Nelson, J. D., Murray, S., Wang, X., Budoff, M. J., Dransfield, M. T., Hokanson, J. E., Kazerooni, E. A., et al. (2017) · Respiratory Research · doi:10.1186/s12931-017-0521-1 · Cited by 35
Self-citationSelman, M., Martinez, F. J., & Pardo, A. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1166pp · Cited by 35
McGroder, C. F., Pistenmaa, C. L., Bielinski, S. J., Kawut, S. M., Tracy, R. P., Raghu, G., Barr, R. G., Lederer, D. J., & Podolanczuk, A. J. (2019) · European Respiratory Journal · doi:10.1183/13993003.00295-2019 · Cited by 29
Testing for genetic association taking into account phenotypic information of relatives
Uh, H., van der Wijk, H. J., & Houwing‐Duistermaat, J. J. (2009) · BMC Proceedings · doi:10.1186/1753-6561-3-s7-s123 · Cited by 18
Cited by
SenNet recommendations for detecting senescent cells in different tissues
Suryadevara, V., Hudgins, A. D., Rajesh, A., Pappalardo, A., Karpova, A., Dey, A. K., Hertzel, A., Agudelo, A., Rocha, A., Soygur, B., et al. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00738-8 · Cited by 408
“There is an association between the upregulation of GDF15, IL-6, CRP and TNFRSF1B in plasma with the susceptibility of the occurrence of interstitial lung abnormalities 179 .”
Aging Biomarker Consortium, Bao, H., Cao, J., Chen, M., Chen, M., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 376
Interstitial Lung Abnormalities: State of the Art
Hata, A., Schiebler, M. L., Lynch, D. A., & Hatabu, H. (2021) · Radiology · doi:10.1148/radiol.2021204367 · Cited by 160
Self-citationPrecision medicine advances in idiopathic pulmonary fibrosis
Karampitsakos, Τ., Juan-Guardela, B. M., Τzouvelekis, Α., & Herazo‐Maya, J. D. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104766 · Cited by 157
Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development
Samarelli, A. V., Masciale, V., Aramini, B., Coló, G. P., Tonelli, R., Marchioni, A., Bruzzi, G., Gozzi, F., Andrisani, D., Castaniere, I., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212179 · Cited by 99
“The MLK family, in particular MLK-3, activates type I collagen expression in human embryonic lung fibroblast cell line [10], and interacts with SMAD3 to bind type I collagen and αSMA promoters [196].”
Background
Metadata
- Authors
- Sanders, J. L., Putman, R. K., Dupuis, J., Xu, H., Murabito, J. M., Araki, T., Nishino, M., Benjamin, E. J., Levy, D., Ramachandran, V. S., Washko, G. R., Curtis, J. L., Freeman, C. M., Bowler, R. P., Hatabu, H., O’Connor, G. T., & Hunninghake, G. M.
- Affiliations
- Division of Pulmonary and Critical Care Medicine and
- Department of Biostatistics, School of Public Health
- Framingham Heart Study (US)
- Brigham and Women's Hospital (US)
- Department of Medicine, and
- University of Michigan (US)
- National Jewish Health (US)
- Boston University (US)
- Corresponding author
- Sanders, Jason L.
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-05-01
- Volume
- 203
- Issue
- 9
- Pages
- 1149-1157
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC8314902
- OpenAlex
- W3094049770
- Cited by
- 84
- References
- 49
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 14 · 2023: 18 · 2022: 14 · 2021: 7
- FWCI
- 5.77
- Type
- journal article
- Language
- en
- Update notices
- correction (2022-09-01)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 CX000911)
- National Institutes of Health (OT2OD026553, n01hc25195-41-0-1)
- National Institute on Aging (R01AG031287, R01AG067457, R01AG028321)
- National Heart, Lung, and Blood Institute (R01HL141434, R01HL144718, HHSN268201500001I, R01 HL077477, HHSN268201500001C, U01HL146408, R01HL089856, R01HL111024, 75N92019D00031, N01-HC-025195, R01HL089897, U01HL089856, K08HL140087, R01HL076784, R21HL140376, R01HL122464, R01HL137995, R01HL130974, T32HL007633, ZIAHL006001, R01HL092577, R01HL135142, U54HL120163)
- National Cancer Institute (R01CA203636)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- aging biomarkers, interstitial lung abnormalities, all-cause mortality, idiopathic pulmonary fibrosis, growth differentiation factor 15, interleukin-6, C-reactive protein, IGFBP-1, cystatin C, HbA1c, aging, chronic obstructive pulmonary disease, causal inference
- MeSH terms
- Adult, Age Factors, Aged, Aging, Female, Humans, Longitudinal Studies, Male, Middle Aged, Biomarkers, Survival Rate, Odds Ratio, Lung Diseases, Interstitial, Growth Differentiation Factor 15
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.